Safety and Immunogenicity of Live Attenuated Influenza H5N2

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
Influenza Due to Influenza A Virus Subtype H5N2
Interventions
BIOLOGICAL

Avian Flu Vaccine

Trial Locations (1)

10400

Faculty of Tropical Medicine, Bangkok

All Listed Sponsors
collaborator

The Government Pharmaceutical Organization

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Mahidol University

OTHER

NCT01841918 - Safety and Immunogenicity of Live Attenuated Influenza H5N2 | Biotech Hunter | Biotech Hunter